Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Juan Carrillo-Reixach, Laura Torrens, Marina Simon‐Coma, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 328-341
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
Feng Ren, Xiao Ding, Min Zheng, et al.
Chemical Science (2023) Vol. 14, Iss. 6, pp. 1443-1452
Open Access | Times Cited: 187
Epigenetic remodelling in human hepatocellular carcinoma
Maria Rita Braghini, Oriana Lo Re, Ilaria Romito, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 50
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Alex Clavería-Cabello, José M. Herranz, M. Ujúe Latasa, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 4, pp. 989-1005
Open Access | Times Cited: 23
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma
Amélie Roehrig, Théo Z. Hirsch, Aurore Pire, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Worldwide burden of liver cancer across childhood and adolescence, 2000–2021: a systematic analysis of the Global Burden of Disease Study 2021
Zenghong Wu, Fangnan Xia, Weijun Wang, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102765-102765
Open Access | Times Cited: 9
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma
Salih Demir, Negin Razizadeh, Émilie Indersie, et al.
Hepatology Communications (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 8
Multiomic analysis uncovers a continuous spectrum of differentiation and Wnt-MDK-driven immune evasion in hepatoblastoma
Daniel Münter, Flavia W. de Faria, Mathis Richter, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 1
Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer
Théo Z. Hirsch, Jill Pilet, Guillaume Morcrette, et al.
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2524-2543
Open Access | Times Cited: 55
The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer
James Pittaway, Constantinos Lipsos, Katia Mariniello, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 12, pp. R271-R287
Open Access | Times Cited: 44
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults
Pavel Sumazin, Tricia Peters, Stephen F. Sarabia, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1026-1037
Open Access | Times Cited: 35
Wnt signaling in liver regeneration, disease, and cancer
Gengyi Zou, Jae‐Il Park
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 33-50
Open Access | Times Cited: 32
A novel risk stratification model based on the Children's Hepatic Tumours International Collaboration-Hepatoblastoma Stratification and deoxyribonucleic acid methylation analysis for hepatoblastoma
Takafumi Kondo, Shohei Honda, Hiromu Suzuki, et al.
European Journal of Cancer (2022) Vol. 172, pp. 311-322
Open Access | Times Cited: 29
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma
Jie Fang, Shivendra V. Singh, Changde Cheng, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
GepLiver: an integrative liver expression atlas spanning developmental stages and liver disease phases
Ziteng Li, Hena Zhang, Qin Li, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 17
DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis
Julie Sanceau, Lucie Poupel, Camille Joubel, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 1125-1143
Open Access | Times Cited: 6
Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma
Rui Sun, Simin Li, Ke Zhao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 37
DNA methylation as a key epigenetic player for hepatoblastoma characterization
Maria Prates Rivas, Talita Ferreira Marques Aguiar, Gustavo Ribeiro Fernandes, et al.
Clinics and Research in Hepatology and Gastroenterology (2021) Vol. 45, Iss. 3, pp. 101684-101684
Closed Access | Times Cited: 37
Molecular Mechanisms of Hepatoblastoma
Yi Zhang, Antonio Solinas, Stefano Cairo, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 01, pp. 028-041
Open Access | Times Cited: 33
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy
Peng Wu, Arun Rangaswami
Current Oncology Reports (2022) Vol. 24, Iss. 9, pp. 1209-1218
Closed Access | Times Cited: 27
LncRNAs and CircRNAs in cancer
Xin Yin, Huiran Lin, Lei Lin, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 24
Making sense of artificial intelligence and large language models—including ChatGPT—in pediatric hematology/oncology
Kirk D. Wyatt, Natasha Alexander, Gerard D. Hills, et al.
Pediatric Blood & Cancer (2024)
Closed Access | Times Cited: 5
Gas1-Mediated Suppression of Hepatoblastoma Tumorigenesis
K C Chen, Huabo Wang, Bingwei Ma, et al.
American Journal Of Pathology (2025)
Open Access
Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma
Yuanqi Wang, Xiao Xiang, Huadong Chen, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 5, pp. 101044-101044
Open Access | Times Cited: 12
Inhibition of Histone Deacetylase Activity Increases Cisplatin Efficacy to Eliminate Metastatic Cells in Pediatric Liver Cancers
Ruhi Gulati, Yasmeen Fleifil, Katherine M. Jennings, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2300-2300
Open Access | Times Cited: 4
Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids
Thomas A. Kluiver, Yuyan Lu, Stephanie A. Schubert, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top